Ema
Techstars '21Houston, US · Founded 2020 · 3 employees on LinkedIn · 10 known investors
Find your way into Ema
Sign up to see every warm intro you have to Ema
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ema team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ema is a clinical AI layer that runs on top of frontier models to add medical judgment, safety guardrails, and clinical rubrics for health and wellness products. It targets companies building AI features in care settings, with an emphasis on women's health, and turns user conversations into de-identified signals teams can act on.
Also known as ema · SocialMama
Investors · 10
How we know: Emmeline Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · research · houston.innovationmap.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$80M disclosed across 1 of 3 rounds · 2024–2026
- $80MraisedJul 2026 · 2 sources
Creaegis
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Sep 2026Ema is a Houston-founded health technology company operating a conversational, AI-based chat product focused on women's health and wellness. The tool covers topics spanning fertility, pregnancy, postpartum and breastfeeding support through menopause, and is designed to respond with speed, accuracy and an empathetic tone, drawing on a proprietary database of expert-backed information. The product is HIPAA-secure, retains conversational memory so that exchanges can be resumed over time, and is structured to surface potential red flags so users can be directed toward positive health outcomes.
The company began as SocialMama, a platform for connecting new mothers, and later added access to women's health experts. After observing that expert conversations were highly repetitive and that round-the-clock human expert coverage would not scale, the team rebuilt the platform around generative pre-trained transformer technology and rebranded to Ema, a name taken from the middle letters of "female." Alongside its direct-to-consumer chat, Ema has moved into business-to-business distribution, embedding its conversational AI inside partner health products.
Founding story
Amanda Ducach launched SocialMama as a social platform for mothers shortly before the COVID-19 pandemic. User demand shifted toward access to information about women's health more broadly, prompting a pivot to connect users with women's health experts. Recognizing that questions to experts were largely repetitive and that 24/7 expert access could not scale, Ducach's team spent roughly 16 months rebuilding the service on GPT technology and rebranded the company as Ema, announced in February 2023, with the stated goal of reducing barriers to care for women facing socioeconomic disparities.
Business model
Ema offers a consumer-facing conversational AI product for women's health and also licenses its chat technology to other companies for integration into their applications, a B2B motion it entered after initially operating direct-to-consumer.
Revenue comes from business contracts for use of its conversational AI platform, reported as $100,000 in contracts within 30 days of launching the B2B offering.
Traction
The platform reported more than 100,000 users and, after pivoting to a B2B model, $100,000 in contracts signed within 30 days. Its integration into Willow Innovations' breastfeeding app extended distribution to that platform's user base.
Latest developments
In November 2024, Ema's conversational AI was integrated into the Willow Innovations app for breastfeeding mothers, following a bridge round that brought total funding to nearly $2 million and an expansion into B2B contracts.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Ema operates in the femtech and maternal health segment, positioning its AI chat as a scalable alternative to one-to-one access to human clinicians such as OB-GYNs and postpartum nurses. It is a portfolio company of HearstLab.
The company positions the product as a continuously available, memory-retaining assistant grounded in expert-vetted content rather than general-purpose chat, with an emphasis on empathy, HIPAA-secure handling of user data, and identification of health red flags that route users toward care.
Technology
The platform is built on generative pre-trained transformer (GPT) language model technology layered over a proprietary database of expert-backed women's health information. It is described as HIPAA-secure, maintains memory of prior conversations, and is tuned for empathetic and compassionate responses as well as for flagging potential clinical concerns.
Go-to-market
Distribution combines a direct consumer chat product with partnerships that embed Ema inside third-party women's health platforms, such as the Willow app for breastfeeding mothers. The company reported signing $100,000 in contracts within 30 days of pivoting to the B2B model.
Women seeking health information across fertility, pregnancy, postpartum, breastfeeding and menopause, including new and expecting mothers; and companies operating women's health and maternal care applications that want to embed conversational AI.
Geography
Headquartered in Houston, Texas, with a partner integration reaching users of a California-based femtech company's app.
History
Sources give differing founding dates for the predecessor company SocialMama: one account states it was founded in 2018 and another that Amanda Ducach founded it in 2019. Ducach was accepted into the Techstars Austin program in 2021. The rebrand and pivot from SocialMama to the AI-based Ema chat tool was reported in February 2023, with a platform launch planned for the following month and plans to raise seed funding and roughly double a ten-person team. By 2024 the company had closed a bridge round taking total funding to nearly $2 million and had begun selling into the B2B market; in November 2024 its conversational AI was integrated into the Willow Innovations app.
Compiled by commissioned research from 10 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsEma's HIPAA-secure conversational AI tool, drawing on a proprietary database of expert-backed information, was added to the Willow app for breastfeeding mothers.
Ema closed a bridge round with investment from Kubera's Venture Capital and Victorum Capital, alongside existing investors Hearst Labs, Wormhole Capital, Acumen America and Techstars, bringing total funding to nearly $2 million.
The Houston femtech company formerly known as SocialMama rebranded to Ema and rebuilt its platform around generative pre-trained transformer technology, offering an AI chat tool covering topics from fertility to menopause, with conversational memory and red-flag detection intended to route users toward care.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 10
primary sources listed
10 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Ema do?
- Ema is a Houston-based AI chat platform delivering evidence-based women's health and maternal support to consumers and partner apps.
- Who are Ema's investors?
- Ema's investors include Connetic Ventures, Emmeline Ventures, Techstars, Victorum, Wormhole Capital, Acumen America.
- How much funding has Ema raised?
- Ema has disclosed $80M raised across 1 of its 3 known rounds.
- Where is Ema headquartered?
- Ema is headquartered in Houston, US.




